drugset
drugset / Trial / NCT03979248

A Study to Investigate the Effects of Gastric Acid Suppression by Rabeprazole and BMS-986165 on How Fast and Complete The Drug is Absorbed Into the Body of Healthy Participants

NCT03979248 ↗

Phase 1 Completed 21 enrolled Bristol-Myers Squibb
NaSequentialOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effects of stomach acid suppression by rabeprazole and BMS-986165 on how fast and complete the drug is absorbed into the body of healthy participants.

Timeline

Start
2019-05-16
Primary completion
2019-07-07
Completion
2019-07-07

Drugs

EvaluationDrugModalityDoseRoute
Subject CRAVACITINIB Small molecule — —
Subject Rabeprazole Small molecule — —

Indications

No indication recorded.